tirzepatide surmount-1 weight loss percent 72 weeks results reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism Tirzepatide before and after: realistic
Description
Clinical data shows that injection site reactions which include redness, itching, or slight swelling are one of the reported side effects
However, experiences vary from person to person
Someone who lost weight on 15mg weekly might transition to 7.5-10mg for maintenance
She ensures that patients are well-informed about potential side effects and monitors their progress closely
Others barely notice it
The new GIP receptor stimulus restarts metabolic pathways that had adapted to pure GLP-1 agonism
